Φορτώνει......
ALLN-177, oral enzyme therapy for hyperoxaluria
PURPOSE: To evaluate the potential of ALLN-177, an orally administered, oxalate-specific enzyme therapy to reduce urine oxalate (UOx) excretion in patients with secondary hyperoxaluria. METHODS: Sixteen male and female subjects with both hyperoxaluria and a kidney stone history were enrolled in an o...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Int Urol Nephrol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer Netherlands
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6459785/ https://ncbi.nlm.nih.gov/pubmed/30783888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11255-019-02098-1 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|